Kim BS - Search Results

1

Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.

Jeung HC, Rha SY, Noh SH, Min JS, Kim BS, Chung HC. Jeung HC, et al. Among authors: kim bs. Cancer. 2001 Jun 1;91(11):2016-25. doi: 10.1002/1097-0142(20010601)91:11<2016::aid-cncr1227>3.0.co;2-i. Cancer. 2001. PMID: 11391580 Clinical Trial.

2

Should all the N3 lymph nodes group metastasis be regarded as distant metastasis (M1) in curatively resected gastric cancer?

Chung HC, Lim HY, Koh EH, Kim JH, Roh JK, Park IS, Min JS, Lee KS, Youn JK, Kim BS, et al. Chung HC, et al. Among authors: kim bs, kim jh. Yonsei Med J. 1992 Jun;33(2):143-52. doi: 10.3349/ymj.1992.33.2.143. Yonsei Med J. 1992. PMID: 1413891 Free article.

3

Locally advanced unresectable gastric cancer successfully resected after neoadjuvant chemotherapy with FADE regimen.

Chung HC, Roh JK, Park YJ, Lee SI, Min JS, Lee JT, Lee KB, Kim BS. Chung HC, et al. Among authors: kim bs. Yonsei Med J. 1990 Mar;31(1):74-9. doi: 10.3349/ymj.1990.31.1.74. Yonsei Med J. 1990. PMID: 2346043 Free article.

4

Overexpression of c-ErbB-2 protein in gastric cancer by immunohistochemical stain.

Lee HR, Kim JH, Uhm HD, Ahn JB, Rha SY, Cho JY, Lee JI, Lee KH, Chung HC, Roh JK, Min JS, Lee KS, Shin DH, Kim BS, Hong SW, Choi JH. Lee HR, et al. Among authors: kim bs, kim jh. Oncology. 1996 May-Jun;53(3):192-7. doi: 10.1159/000227559. Oncology. 1996. PMID: 8643220

5

High level of urokinase-type plasminogen activator is a new prognostic marker in patients with gastric carcinoma.

Cho JY, Chung HC, Noh SH, Roh JK, Min JS, Kim BS. Cho JY, et al. Among authors: kim bs. Cancer. 1997 Mar 1;79(5):878-83. Cancer. 1997. PMID: 9041148

6

P-glycoprotein as an intermediate end point of drug resistance to neoadjuvant chemotherapy in locally advanced gastric cancer.

Chung HC, Gong SJ, Yoo NC, Noh SH, Kim JH, Roh JK, Min JS, Kim BS, Lee KB. Chung HC, et al. Among authors: kim bs, kim jh. Yonsei Med J. 1996 Dec;37(6):397-404. doi: 10.3349/ymj.1996.37.6.397. Yonsei Med J. 1996. PMID: 9048492 Free article.

7

P-glycoprotein: the intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer.

Chung HC, Rha SY, Kim JH, Roh JK, Min JS, Lee KS, Kim BS, Lee KB. Chung HC, et al. Among authors: kim bs, kim jh. Breast Cancer Res Treat. 1997 Jan;42(1):65-72. doi: 10.1023/a:1005739525196. Breast Cancer Res Treat. 1997. PMID: 9116319

8

Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate.

Rha SY, Noh SH, Kwak HJ, Wellstein A, Kim JH, Roh JK, Min JS, Kim BS, Chung HC. Rha SY, et al. Among authors: kim bs, kim jh. Cancer Lett. 1997 Sep 16;118(1):37-46. doi: 10.1016/s0304-3835(97)00215-2. Cancer Lett. 1997. PMID: 9310258 Free article.

9

Retrospective comparison of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (modified FAM) combination chemotherapy versus palliative therapy in treatment of advanced gastric cancer.

Park JO, Chung HC, Cho JY, Rha SY, You NC, Kim JH, Noh SH, Kim CB, Min JS, Kim BS, Roh JK. Park JO, et al. Among authors: kim cb, kim bs, kim jh. Am J Clin Oncol. 1997 Oct;20(5):484-9. doi: 10.1097/00000421-199710000-00010. Am J Clin Oncol. 1997. PMID: 9345333

10

An unusual case of gastric carcinoma with synchronous non-Hodgkin's lymphoma.

Park SH, Rha SY, Shim DK, Rho HJ, Yoo NC, Kim JH, Roh JK, Yang WI, Noh SH, Min JS, Kim BS, Chung HC. Park SH, et al. Among authors: kim bs, kim jh. Yonsei Med J. 1998 Oct;39(5):463-7. doi: 10.3349/ymj.1998.39.5.463. Yonsei Med J. 1998. PMID: 9821796 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,774 results

Search Page

Filters